Fertility warning
This medicine may affect fertility.
Leaflet CARMUSTINE 100mg powder and solvent for solution for infusion
- Product code:
- W64966001
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- infusion
- Substance:
- carmustine (antineoplastic agent)
- ATC
- L01AD01 — Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Carmustine is a chemotherapy medication used to treat certain types of cancer, including lymphomas, multiple myeloma, and brain tumors. It belongs to the class of alkylating agents and works by interfering with the DNA of cancer cells, inhibiting their division and growth.
Carmustine is administered intravenously or as implants in the case of brain tumors. Treatment is usually given in cycles, and the dosage is adjusted based on the patient's weight, overall health, and the type of cancer being treated.
Patients need to be closely monitored during treatment to detect potential side effects, such as pulmonary toxicity, decreased blood cell counts, or liver function impairment. It is important to strictly follow the doctor's instructions.
Common side effects include nausea, vomiting, fatigue, and an increased risk of infections. In rare cases, more severe complications such as pulmonary fibrosis or liver failure may occur. Patients should inform their doctor of any unusual symptoms.
Carmustine is administered intravenously or as implants in the case of brain tumors. Treatment is usually given in cycles, and the dosage is adjusted based on the patient's weight, overall health, and the type of cancer being treated.
Patients need to be closely monitored during treatment to detect potential side effects, such as pulmonary toxicity, decreased blood cell counts, or liver function impairment. It is important to strictly follow the doctor's instructions.
Common side effects include nausea, vomiting, fatigue, and an increased risk of infections. In rare cases, more severe complications such as pulmonary fibrosis or liver failure may occur. Patients should inform their doctor of any unusual symptoms.
General data about CARMUSTINE 100mg
- Substance:
- carmustine
- Date of latest medicines list:
- 01-11-2021
- Product code:
- W64966001
- Concentration:
- 100mg
- Pharmaceutical form:
- powder and solvent for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.